E-LIB Suche - Ergebnisse für: Davies, Faith C. J.

1

Face-valid phenotypes in a mouse model of the most common m..:

Marshall, Grant F. ; Fasol, Melissa ; Davies, Faith C. J....
Disease Models & Mechanisms. 17 (2024) 6 - p. , 2024

2

Endogenous epitope tagging of eEF1A2 in mice reveals early ..:

Davies, Faith C.J. ; Marshall, Grant F. ; Pegram, Eleanor..
Molecular and Cellular Neuroscience. 126 (2023) - p. 103879 , 2023

Link: https://doi.org/10.1016/..

3

Recapitulation of the EEF1A2 D252H neurodevelopmental disor..:

Davies, Faith C J ; Hope, Jilly E ; McLachlan, Fiona...
Human Molecular Genetics. 29 (2020) 10 - p. 1592-1606 , 2020

Link: https://doi.org/10.1093/..

4

Biallelic mutations in the gene encoding eEF1A2 cause seizu..:

Davies, Faith C. J. ; Hope, Jilly E. ; McLachlan, Fiona...
Scientific Reports. 7 (2017) 1 - p. , 2017

Link: https://doi.org/10.1038/..

5

Efficient and versatile CRISPR engineering of human neurons..:

Shah, Ruth R. ; Cholewa-Waclaw, Justyna ; Davies, Faith C.J....
Wellcome Open Research. 1 (2016) - p. 13 , 2016

Link: https://doi.org/10.12688..

6

In vivocharacterization of the role of tissue‐specific tran..:

Doig, Jennifer ; Griffiths, Lowri A. ; Peberdy, David...
The FEBS Journal. 280 (2013) 24 - p. 6528-6540 , 2013

Link: https://doi.org/10.1111/..

7

Haploinsufficiency for Translation Elongation Factor eEF1A2..:

Griffiths, Lowri A. ; Doig, Jennifer ; Churchhouse, Antonia M. D....
PLoS ONE. 7 (2012) 7 - p. e41917 , 2012

Link: https://doi.org/10.1371/..

8

Efficient and versatile CRISPR engineering of human neurons..:

Shah, Ruth Rama ; Cholewa-Waclaw, Justyna ; Davies, Faith C.J...
https://zenodo.org/record/163342. , 2016

Link: https://zenodo.org/recor..

9

In vivo characterization of the role of tissue‐specific tra..:

Doig, Jennifer ; Griffiths, Lowri A ; Peberdy, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2013

Link: http://www.ncbi.nlm.nih...

10

Anthropometric traits and risk of multiple myeloma: differe..:

Arnold, Kevin D. ; Ong, Krystle L. ; Ravi, Gayathri...
British Journal of Cancer. 131 (2024) 2 - p. 312-324 , 2024

Link: https://doi.org/10.1038/..

11

Impact of prior lenalidomide or proteasome inhibitor exposu..:

Lee, Hans C. ; Ramasamy, Karthik ; Macro, Margaret...
European Journal of Haematology. 113 (2024) 2 - p. 190-200 , 2024

Link: https://doi.org/10.1111/..

12

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 3 - p. e171-e181 , 2023

Link: https://doi.org/10.1016/..

13

Perspectives on the Risk-Stratified Treatment of Multiple M..:

Davies, Faith E. ; Pawlyn, Charlotte ; Usmani, Saad Z....
Blood Cancer Discovery. 3 (2022) 4 - p. 273-284 , 2022

Link: https://doi.org/10.1158/..

14

Ixazomib-Lenalidomide-Dexamethasone in Routine Clinical Pra..:

Hájek, Roman ; Minařík, Jiří ; Straub, Jan...
Future Oncology. 17 (2021) 19 - p. 2499-2512 , 2021

Link: https://doi.org/10.2217/..

15

Predicting ultrahigh risk multiple myeloma by molecular pro..:

on behalf of NCRI Haematology Clinical Studies Group ; Shah, Vallari ; Sherborne, Amy L....
Leukemia. 34 (2020) 11 - p. 3091-3096 , 2020

Link: https://doi.org/10.1038/..